FDA Grants Full Approval to New Alzheimer’s Drug Meant to Slow Disease
The Food and Drug Administration on Thursday fully approved the Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility. The move marks the first time that a drug…
